ZBD | $40,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Asymmetric Security | $4,200,000 | (Jan 23, 2026)
Certified by Founder
Lodge
hema.to GmbH
start up
Germany
- Munich
- 07/03/2025
- Unknown
- $3,900,060
We are a deeptech AI company obsessed with solving cytometry and thereby make an outsized and lasting impact on immune medicine: we want to make sure every patient gets the right treatment at the right time for their unique immune systems.
- Industry Software Development
- Website https://www.hema.to/
- LinkedIn https://www.linkedin.com/company/hemato/
Related People
Karsten MiermansFounder
Germany -
Munich, Bavaria
Founder of an AI diagnostic start-up, passionate about improving cytometry and blood cancer diagnostics. I have a background in theoretical biophysics, but I'm a generalist at heart. My fundamental drivers are growth, honesty, efficiency and curiosity. In my spare time, I enjoy reading great works, electronic music and teaching rationality.
Cubby | $63,000,000 | (Jan 23, 2026)
Cambio | $18,000,000 | (Jan 23, 2026)
Cork Protocol | $5,500,000 | (Jan 23, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)
Mendra | $82,000,000 | (Jan 23, 2026)
Artie Technologies | $12,000,000 | (Jan 23, 2026)
Antidote Legal | $5,000,000 | (Jan 23, 2026)
One to One Health | $12,000,000 | (Jan 22, 2026)